相关实验视频
Updated: Jul 1, 2025

07:37
An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
97
联合组装纳米药物通过甲索和巴里西提尼布之间的分子间相互作用进行介导,以改善类风湿性关节炎治疗
Hehe Xiong1, Heng Zhang1, Yatong Qin1
1State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory & Center for Molecular Imaging and Translational Medicine, School of Public Health, Xiamen University, Xiamen 361102, China.
ACS nano
|March 4, 2024
概括
这项研究揭示了如何结合甲醇 (MTX) 和巴里西丁尼 (BTN) 形成纳米纤维,用于增强类风湿性关节炎 (RA) 治疗. 这些纳米微粒利用药物协同作用来改善抗炎和抗增殖作用.
科学领域:
- 药物输送系统是药物输送系统.
- 纳米医学是一种纳米医学.
- 类风湿性关节炎的治疗药物
背景情况:
- 甲基 (MTX) 和巴里西丁尼布 (BTN) 组合疗法在风湿性关节炎 (RA) 中显示出前景.
- 对于MTX-BTN组合纳米医学的协同机制和合理设计策略仍然未得到充分探索.
研究的目的:
- 研究MTX和BTN之间的分子间相互作用.
- 开发一种新的纳米药物配方,用于增强RA治疗.
- 阐明开发的纳米医学的协同治疗效应.
主要方法:
- 利用N-异环环相互作用 (键,π-π堆叠) 来形成纳米纤维.
- 将MTX和BTN联合组装成2:1重量比的纳米纤维 (MB NV).
- 在体外和体内都对抗RA疗效进行了评估.
主要成果:
- MTX和BTN自组装成由分子间相互作用驱动的精致囊状纳米囊 (MB NVs).
- 与单个药物相比,MB NVs (2:1) 显示出优异的抗RA作用.
- 观察到协同的抗炎和抗增殖反应.
结论:
- 分子间药物相互作用可以引导联合组装进入纳米医学.
- 组合纳米医学的合理设计可以实现协同治疗效果.
- 这项研究为开发用于RA治疗的先进纳米药物提供了洞察力.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
137
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
137
Genome-wide Association Studies-GWAS
13.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.4K
The JAK-STAT Signaling Pathway
8.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.9K
Combined Effects of Drugs: Synergism
3.9K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.9K
Combined Effects of Drugs: Antagonism
8.5K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
8.5K
Protein Complex Assembly
10.6K
Proteins can form homomeric complexes with another unit of the same protein or heteromeric complexes with different types. Most protein complexes self-assemble spontaneously via ordered pathways, while some proteins need assembly factors that guide their proper assembly. Despite the crowded intracellular environment, proteins usually interact with their correct partners and form functional complexes.
Many viruses self-assemble into a fully functional unit using the infected host cell to...
Many viruses self-assemble into a fully functional unit using the infected host cell to...
10.6K

